CNHCChina Health Management Corp.
The schedule
- Thu15Oct
Expected window for the shell to announce a definitive Letter of Intent (LOI) or reverse merger target. A successful announcement could trigger a repricing to $0.015, while silence likely collapses the floor to $0.002.
- Mon16Nov
Q3 2026 earnings release, serving as a critical checkpoint for transaction expenses and capitalized merger costs. Constructive deal progress could elevate shares to $0.02, whereas a stalled process threatens a retreat to $0.008.
- Mon15Feb
Final anticipated deadline for proxy filing and shareholder approval of a reverse merger. Securing the transaction pushes the equity toward a $0.025 post-deal valuation, while deal termination drops the shell to $0.001.
- Fri28May
- Fri27Aug
Past
- Fri28Aug
Release of Q2 2026 earnings, providing an update on the company's precarious liquidity position and any forward guidance on strategic alternatives. A favorable update could push the stock to $0.011, while ongoing cash burn without M&A progress risks a drop to $0.005.